INmune Bio, Inc. (INMB) Tops Q1 EPS by 7c
INmune Bio, Inc. (NASDAQ: INMB) reported Q1 EPS of ($0.20), $0.07 better than the analyst estimate of ($0.27).
For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.
INmune Bio, Inc. (NASDAQ: INMB) reported Q1 EPS of ($0.20), $0.07 better than the analyst estimate of ($0.27).
For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.